Brainfutures Incorporated

Psychedelicsdeveloped professional practice guidelines and a coding guide for a new therapeutic approach to treat brain-based conditions including depression and ptsd. Educated the public through issue briefs, conference presentations to professional audiences, and authoring articles for select national publications. Interviewed a wide range of health care, academic and philanthropic stakeholders to better understand and address potential barriers to psychedelic-assisted therapy access for all.